Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Conditions:   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Hematopoietic and Lymphoid Cell Neoplasm;   Hodgkin Lymphoma;   Myelodysplastic Syndrome;   Non-Hodgkin Lymphoma;   Plasma Cell Myeloma Interventions:   Procedure: Bioelectric Impedance Analysis;   Procedure: Biospecimen Collection;   Procedure: Cardiopulmonary Exercise Testing;   Procedure: Echocardiography;   Procedure: Physical Performance Testing;   Procedure:&n...
Source: ClinicalTrials.gov - September 3, 2020 Category: Research Source Type: clinical trials

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Conditions:   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Hematopoietic and Lymphoid Cell Neoplasm;   Hodgkin Lymphoma;   Myelodysplastic Syndrome;   Non-Hodgkin Lymphoma;   Plasma Cell Myeloma Interventions:   Procedure: Bioelectric Impedance Analysis;   Procedure: Biospecimen Collection;   Procedure: Cardiopulmonary Exercise Testing;   Procedure: Echocardiography;   Procedure: Physical Performance Testing;   Procedure:&n...
Source: ClinicalTrials.gov - September 3, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - T Cells
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Antibody
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Seroprotection
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Seroprotection
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Seroprotection
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Seroprotection
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Influenza Vaccine in Lung Transplant Patients - Seroprotection
Condition:   Influenza Intervention:   Drug: Influenza vaccine Sponsor:   University of Wisconsin, Madison Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials